Barely Significant
← all excerpts

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil.

Drug Des Devel Ther · 2020 · PMC7431170 · PMID 32848364

Europe PMCDOI
1
hedged sentence
0.0660
closest p · 1.3× alpha
0.0660
boldest claim

The sentences

borderline significantp=0.066so close (0.05 < p ≤ 0.1)
This factor was borderline significant in our study (p=0.066 for gene dose; p=0.031 for type of metabolizer).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.